Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. (Q44395938)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 October 2007

Language	Label	Description	Also known as
English	Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.	scientific article published on 24 October 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

1 reference

based on heuristic

inferred from title

Henderik W Frijlink

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Amorij JP

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Saluja V

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Petersen AH

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Hinrichs WL

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Huckriede A

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

0 references

publication date

24 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

52

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

8707-8717

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17996993%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Immunity to influenza in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Avian influenza virus infections in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Intranasal immunization with inactivated influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Effective nasal influenza vaccine delivery using chitosan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Mucosal immunity and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Absorption Enhancers for Nasal Drug Delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Trivalent intranasal influenza vaccine, live

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Needle-free vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Alternative routes of influenza vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Noninvasive delivery technologies: respiratory delivery of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Pulmonary dendritic cells in local immunity to inert and pathogenic antigens in the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Mucosal immunity: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Investigations into the stabilisation of drugs by sugar glasses: II. Delivery of an inulin-stabilised alkaline phosphatase in the intestinal lumen via the oral route

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Non-invasive pulmonary aerosol delivery in mice by the endotracheal route

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

A sensitive ELISPOT assay to detect low-frequency human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Descriptors of irregular particle morphology and powder properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Large porous particles for pulmonary drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Protein inhalation powders: spray drying vs spray freeze drying

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

The role of particle engineering in relation to formulation and de-agglomeration principle in the development of a dry powder formulation for inhalation of cetrorelix.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Antigen sampling across epithelial barriers and induction of mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Respiratory host defenses--surface immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Morphological aspects of particle uptake by lung phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Lung macrophages: how many kinds are there? What do they do?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Mucosal immunoadjuvant activity of liposomes: role of alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Inulin glasses for the stabilization of therapeutic proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.035

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44395938&oldid=1877726720"